{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:14:35Z","timestamp":1774289675241,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011990","name":"Nanjing Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The gut microbiome is clearly linked to the development of various autoimmune diseases, however, its association with immune thrombocytopenia (ITP) is less well understood. The current study collected 73 samples, including 36 from healthy individuals and 37 from ITP patients. The gut microbial community was assessed using 16s rRNA sequencing. Findings illustrated that the abundance of key microbiota was significantly higher in the ITP group. This group was further divided into three subgroups that received different treatments for ITP. A random forest model was used to predict the key microbiota and the identified bacteria were shown to easily distinguish between the healthy and the ITP treatment groups. Microbial function annotation and difference analysis showed that drug treatment changed the gut microbiota and may play a role in inducing host autoimmune responses by changing microbial metabolism pathways. Clinical indices also correlated negatively with changes in the microbiota after treatment. In summary, ITP patients who received drug treatment had significant differences in their microbiota along with a high abundance of bacteria. Thus, the microbiome could be used as a biomarker to distinguish between healthy and ITB groups. The key differential bacteria could help to regulate the number of platelets in ITP patients and provide a red blood cell overstock.<\/jats:p>","DOI":"10.3389\/fcimb.2023.1168756","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T04:39:06Z","timestamp":1684125546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Gut microbiota were altered with platelet count and red blood cell count in immune thrombocytopenia patients with different treatments"],"prefix":"10.3389","volume":"13","author":[{"given":"Xue","family":"Rui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengtao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1182\/blood.V80.1.162.162","article-title":"Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura","volume":"80","author":"Bettaieb","year":"1992","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S352","DOI":"10.14309\/00000434-201110002-00941","article-title":"Reversal of idiopathic thrombocytopenic purpura [ITP] with fecal microbiota transplantation [FMT]","volume":"106","author":"Borody","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1182\/blood-2007-03-079913","article-title":"Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura","volume":"111","author":"Breunis","year":"2008","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41584-019-0196-8","article-title":"Gut microbiota linked to kidney disease in SLE","volume":"15","author":"Collison","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","article-title":"UCHIME improves sensitivity and speed of chimera detection","volume":"27","author":"Edgar","year":"2011","journal-title":"Bioinformatics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1590\/S1517-83822013000400002","article-title":"Biotechnology of polyketides: new breath of life for the novel antibiotic genetic pathways discovery through metagenomics","volume":"44","author":"Gomes","year":"2013","journal-title":"Braz. J. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e01548","DOI":"10.1128\/mBio.01548-14","article-title":"Intestinal dysbiosis associated with systemic lupus erythematosus","volume":"5","author":"Hevia","year":"2014","journal-title":"mBio"},{"key":"B11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40168-021-01114-w","article-title":"Hum gut: a comprehensive human gut prokaryotic genomes collection filtered by metagenome data","volume":"9","author":"Hiseni","year":"2021","journal-title":"Microbiome"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1517\/13543784.2012.727395","article-title":"Terpenoids: natural products for cancer therapy","volume":"21","author":"Huang","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1523-5378.2007.00477.x","article-title":"Immune response to CagA protein is associated with improved platelet count after helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura","volume":"12","author":"Kodama","year":"2007","journal-title":"Helicobacter"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00744","article-title":"Inflammation-related gene polymorphisms associated with primary immune thrombocytopenia","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"101886","DOI":"10.1016\/j.redox.2021.101886","article-title":"Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction","volume":"41","author":"Li","year":"2021","journal-title":"Redox Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nm.4358","article-title":"Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention","volume":"23","author":"Liu","year":"2017","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.803627","article-title":"EasyMicroPlot: an efficient and convenient r package in microbiome downstream analysis and visualization for clinical study","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4161\/gmic.25486","article-title":"Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation","volume":"4","author":"Maharshak","year":"2013","journal-title":"Gut Microbes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood.V91.10.3616","article-title":"Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura","volume":"91","author":"Nomura","year":"1998","journal-title":"Blood"},{"key":"B21","unstructured":"OksanenJ.\n            Guillaume BlanchetF.\n            FriendlyM.\n            KindtR.\n            LegendreP.\n            McGlinnD.\n          Vegan: community ecology package2019"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1182\/blood-2013-05-501858","article-title":"Fcgamma receptor IIB gene polymorphism in adult Japanese patients with primary immune thrombocytopenia","volume":"122","author":"Satoh","year":"2013","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/09537100400015153","article-title":"High prevalence of sustained remission of idiopathic thrombocytopenic purpura after helicobacter pylori eradication: a long-term follow-up study","volume":"16","author":"Veneri","year":"2005","journal-title":"Platelets"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3748\/wjg.v27.i21.2834","article-title":"Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation","volume":"27","author":"Wen","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13059-017-1271-6","article-title":"Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis","volume":"18","author":"Wen","year":"2017","journal-title":"Genome Biol."},{"key":"B29","doi-asserted-by":"crossref","unstructured":"XuS.\n            YuG.\n          MicrobiotaProcess: a comprehensive r package for managing and analyzing microbiome and other ecological data within the tidy framework2022","DOI":"10.21203\/rs.3.rs-1284357\/v1"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1848158","article-title":"Gut bacteroides species in health and disease","volume":"13","author":"Zafar","year":"2021","journal-title":"Gut Microbes"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01550","article-title":"Gut microbiome and metabolome were altered and strongly associated with platelet count in adult patients with primary immune thrombocytopenia","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2008-09-181073","article-title":"Role of molecular mimicry of hepatitis c virus protein with platelet GPIIIa in hepatitis c-related immunologic thrombocytopenia","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J. Clin. Med."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1168756\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T04:39:17Z","timestamp":1684125557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1168756\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":33,"alternative-id":["10.3389\/fcimb.2023.1168756"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1168756","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"article-number":"1168756"}}